Monday, September 10, 2012

• AstraZeneca unit and WuXi in China joint ventureAP (Mon, Sep 10)
• Lung Cancer Genomic Mapping Yields New Targets, Researchers Sayat Bloomberg (Mon, Sep 10)

Thursday, September 6, 2012

• What Neil Woodford Has Been Buyingat Motley Fool (Thu, Sep 6)
• Head to Head: GlaxoSmithKline vs. AstraZenecaat Motley Fool (Thu, Sep 6)
• New Brooms to Sweep Clean at Astra and Barclaysat Motley Fool (Thu, Sep 6)

Saturday, September 1, 2012

• Are These 5 FTSE 100 Stalwarts Good Values?at Motley Fool (Sat, Sep 1)
• Hunker Down With These 3 Defensive Sharesat Motley Fool (Sat, Sep 1)

Friday, August 31, 2012

• Are These the Ultimate Retirement Shares?at Motley Fool (Fri, Aug 31)

Thursday, August 30, 2012

• The FTSE's Worst Boardsat Motley Fool (Thu, Aug 30)

Tuesday, August 28, 2012

• AstraZeneca Names New CEO, Faces More Competitionat Bloomberg (Tue, Aug 28)
• A New CEO for AstraZenecaat Motley Fool (Tue, Aug 28)
• G4S First-Half Profit Plunges 73%at Bloomberg (Tue, Aug 28)
• SocGen Favors BAT, Aztraneca, H&M, Tescoat Bloomberg (Tue, Aug 28)
• AstraZeneca Names Roche’s Pascal Soriot as CEOat Bloomberg (Tue, Aug 28)
• Meet AstraZeneca's New Chief Executiveat Bloomberg (Tue, Aug 28)
• Roche Names O’Day Pharma Head as Soriot Becomes AstraZeneca CEOat Bloomberg (Tue, Aug 28)

Monday, August 27, 2012

• Bayer’s Xarelto Helped Survival After Heart Attack: Studyat Bloomberg (Mon, Aug 27)

Saturday, August 25, 2012

• Is FTSE 100 Stalwart AstraZeneca a Good Value?at Motley Fool (Sat, Aug 25)

Friday, August 24, 2012

• My Verdict on 5 FTSE Boardroomsat Motley Fool (Fri, Aug 24)

Thursday, August 23, 2012

• AstraZeneca: Buy, Sell Or Hold?at Motley Fool (Thu, Aug 23)
• The FTSE's Make-or-Break Sharesat Motley Fool (Thu, Aug 23)
• Is AstraZeneca the Ultimate Retirement Share?at Motley Fool (Thu, Aug 23)

Sunday, August 19, 2012

• The Men Who Run AstraZenecaat Motley Fool (Sun, Aug 19)

Thursday, August 16, 2012

• 5 Neil Woodford Low-P/E Sharesat Motley Fool (Thu, Aug 16)

Wednesday, August 15, 2012

• Pfizer, Green Mountain, Google: Intellectual Propertyat Bloomberg (Wed, Aug 15)

Add AZN.L News to My Yahoo!